Navigation Links
Korea Health Industry Development Institute, Be Ready for attracting Patients in States (Hold Korea Global Healthcare Conference with CKMP)
Date:7/8/2009

Korea Health Industry Development Institute (President Kim, Bup-Wan, KHIDI) and Council for Korea Medicine Overseas Promotion (President Sung, Sangchul, CKMP) will hold Korea Global Healthcare Conference to make promotion and exposure to attract patients in U.S. from July 16 to 18, 2009 in New York and San Francisco.

New York, NY (PRWEB) July 8, 2009 -- Korea Health Industry Development Institute (President Kim, Bup-Wan, KHIDI) and Council for Korea Medicine Overseas Promotion (President Sung, Sangchul, CKMP) will hold Korea Global Healthcare Conference to make promotion and exposure to attract patients in U.S. from July 16 to 18, 2009 in New York and San Francisco.

Korea Global Healthcare Conference aims to make promote Korean healthcare services and provide a business network for interested parties. It is going to be held along with Jeon, Jae Hee (Minister of Ministry for Health, Welfare and Family Affairs)'s tour of U.S. Also, Health Industry Institutes such as Ministry for Health, Welfare and Family Affairs, KHIDI, and CKMP, Korean Embassies in United States and Representatives of Korean-American, Korean healthcare providers, Korean companies in United States, insurance companies in United States, medical agencies will participate in the conference.

Thirteen various hospitals and clinics of CKMP and medical Tourism Facilitator will have a session to introduce policies of Korean government and as well as Korean healthcare services in the first session of this conference. The conference will also provide a chance to have a discussion about the current status of healthcare systems in U.S. and Korea, and possibilities of success of American patients to seek treatments from Korea as well as to introduce diverse current projects of American patient's movement to Korea.

Jeon, Jae-Hee (Minister of Ministry for Health, Welfare and Family Affairs) will appoint representatives o
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. China Medical Technologies Announces Receipt of Korean FDA Approval for its HIFU System
2. CHRI Gets Great Progress on the Korean Herb Market
3. CDI-Life Sciences Selected by CJ CheilJedang Corp. to Provide Engineering Design for Major Pharmaceutical Complex in Korea
4. Labopharms Once-Daily Tramadol Approved in South Korea and Australia
5. Cynosures Accolade(TM) Workstation for Pigmented Lesions Receives Korean Regulatory Approval
6. CoorsTek Holds Grand Opening for Newest Facility in South Korea
7. KMDs CHA Hospital, Korea Wins 2008 AIA National Healthcare Award
8. Most Influential Events for Koreas Fine and Specialty Chemical and Pharmaceutical Industries to be Held in November
9. Labopharms Once-Daily Tramadol Product Launched in South Korea, Australia, Romania and Austria
10. Tigermed Forms Strategic Partnerships With Leading CROs in Russia and South Korea
11. Chronic gastrointestinal symptoms in Korean population
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines 2Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines 3Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7Royalty Pharma Announces that Alexander von Perfall Joins Management Team 2Kaiser Permanente Recognized by National Committee for Quality Assurance for Innovative Efforts to Reduce Health Care Disparities 59303 1Kaiser Permanente Recognized by National Committee for Quality Assurance for Innovative Efforts to Reduce Health Care Disparities 59303 2Kaiser Permanente Recognized by National Committee for Quality Assurance for Innovative Efforts to Reduce Health Care Disparities 59303 3Kaiser Permanente Recognized by National Committee for Quality Assurance for Innovative Efforts to Reduce Health Care Disparities 59303 4Laser Spine Institute Helping Patients with Debilitating Back Pain at New Medical Consultation Facilities in Beverly Hills and Fort Lauderdale 59298 1Laser Spine Institute Helping Patients with Debilitating Back Pain at New Medical Consultation Facilities in Beverly Hills and Fort Lauderdale 59298 2Sono Tek Announces Second Quarter Results 5398 1Sono Tek Announces Second Quarter Results 5398 2Sono Tek Announces Second Quarter Results 5398 3